Meridiem Capital Partners LP Charles River Laboratories International, Inc. Transaction History
Meridiem Capital Partners LP
- $1.56 Trillion
- Q3 2025
A detailed history of Meridiem Capital Partners LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Meridiem Capital Partners LP holds 70,467 shares of CRL stock, worth $11.8 Million. This represents 0.7% of its overall portfolio holdings.
Number of Shares
70,467
Previous 120,034
41.29%
Holding current value
$11.8 Million
Previous $18.2 Billion
39.46%
% of portfolio
0.7%
Previous 1.29%
Shares
2 transactions
Others Institutions Holding CRL
# of Institutions
643Shares Held
51.6MCall Options Held
194KPut Options Held
174K-
Vanguard Group Inc Valley Forge, PA5.84MShares$980 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$854 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.19MShares$535 Million0.09% of portfolio
-
Allspring Global Investments Holdings, LLC2.18MShares$365 Million0.61% of portfolio
-
State Street Corp Boston, MA1.83MShares$307 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.54B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...